On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry

Therapeutic Drug Monitoring

Volumn 18, Issue 4, 1996, Pages 465-470

  Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Analysis; Designer drugs; Gas chromatography mass spectrometry; Metabolism; Methylenedioxyphenylalkylamines

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; 3,4 METHYLENEDIOXYAMPHETAMINE; BENZODIOXAZOLYLBUTANAMINE; DESIGNER DRUG; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG ISOLATION; DRUG METABOLISM; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; ISOLATION PROCEDURE; MASS SPECTROMETRY; PRIORITY JOURNAL; TOXICOLOGY;

3,4-METHYLENEDIOXYAMPHETAMINE; CHROMATOGRAPHY, GAS; DESIGNER DRUGS; HALLUCINOGENS; HUMANS; MASS SPECTROMETRY;

EID: 0029789280     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199608000-00027     Document Type: Conference Paper

References (43)

1. Gouzoulis E, Steiger A, Ensslin HK, Kovar K-A, Hermle L. Sleep EEG effects of 3,4-methylenedioxyethylamphetamine (MDE, "Eve") in healthy volunteers. Biol Psychiatry 1992;32:1108-17.
2. Nichols DE, Hoffman AJ, Oberlender RA, Jacob P, Shulgin AT. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamines: representatives of a novel therapeutic class. J Med Chem 1986;29:2009-15.
3. Nichols DE. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 1986;18:305-13.
4. Stone DM, Johnson M, Hanson GR, Gibb JW. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives. Eur J Pharmacol 1987;134:245-8.
5. Singarajah C, Lavies NG. An overdose of ecstasy. Anaesthesia 1992;47:686-7,
6. McGuire P, Fahy T. Flashbacks following MDMA. J Psychiatry 1992;160:276-85.
7. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine. Lancet 1992; 340:384-7.
8. Dowling GP, McDonough ET, Bost RO. "Eve" and "Ecstasy." A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987;257:1615-7.
9. Gouzoulis E, Borchardt D, Hermle L. A case of toxic psychosis induced by "Eve" (3,4-methylenedioxyethylamphetamine). Arch Gen Psychiatry 1993;50:75.
10. Cregg MT, Tracey JA. Ecstasy abuse in Ireland. Ir Med J 1993;86:118-20.
11. Manchada S, Connolly MJ. Cerebral infarction in association with ecstasy abuse. Postgrad Med J 1993;69:874-5.
12. Marquardt GM, DiStefano V, Ling JJ. Metabolism of 3,4-methylenedioxyamphetamine in the rat. Biochem Pharmacol 1978;27:1503-5.
13. Lin LY, Kumagai Y, Cho AK. Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem Res Toxicol 1992;5:401-6.
14. Marquardt GM, DiStefano V. The hepatic microsomal metabolism of 3,4-methylenedioxyamphetamine (MDA). Life Sci 1974;15:1603-10.
15. Lim HK, Foltz RL. In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector. Chem Res Toxicol 1988;1:370-8.
16. Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats. Drug Alcohol Depend 1990;26:127-35.
17. Gollamudi R, Ali SF, Lipe G, et al. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology 1989;10:455-66.
18. Maurer HH, Ensslin H, Kovar K-A. On the metabolism of designer drugs. Part I: studies on methylenedioxyetilamfetamine (MDE) in rats. Bull Soc Sci Med Grand Duche Lux 1990;127:467-71.
19. Lim HK, Foltz RL. Identification of metabolites of 3,4-(methylenedioxy)methamphetamine in human urine. Chem Res Toxicol 1989;2:142-3.
20. Cody JT. Detection of D,L-amphetamine, D,L-methamphetamine and illicit amphetamine analogues using Diagnostic Products Corporation's Amphetamine and Methamphetamine Radioimmunoassay. J Anal Toxicol 1990;14:321-4.
21. Kunsman GW, Manno JE, Cockerham KR, Manno BR. Application of the Syva EMIT and Abbott TDx amphetamine immunoassay to the detection of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyethamphetamine (MDE) in urine. J Anal Toxicol 1990;14:149-53.
22. Poklis A, Fitzgerald RL, Hall KV, Saady JJ. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Forensic Sci Int 1993;59:63-70.
23. Cody JT, Schwarzhoff R. Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogues. J Anal Toxicol 1993;17:26-30.
24. Maurer HH, Kraemer T. Toxicological detection of selegiline and its metabolites in urine using fluorescence polarisation immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from an abuse of methamphetamine or amphetamine. Arch Toxicol 1992;66:675-8.
25. Tedeschi L, Frison G, Castagna F, Giorgetti R, Ferrara SD. Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV. Int J Legal Med 1993;105: 265-9.
26. Helmlin HJ, Brenneisen R. Determination of psychotropic phenylalkylamine derivatives in biological matrices by high performance liquid chromatography with photodiode-array detection. J Chromatogr 1992;593:87-94.
27. Michel RE, Rege AB, George WJ. High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues. J Neurosci Methods 1993;50:61-6.
28. Noggle FT Jr, Clark CR, Andurkar S, DeRuiter J. Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA). J Chromatogr Sci 1991;29:103-6.
29. Can BK, Baugh D, Liu RH, Walia AS. Simultaneous analysis of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry. J Forensic Sci 1991;36:1331-41.
30. Thompson WC, Dasgupta A. Microwave-induced rapid preparation of fluoro derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays. Clin Chem 1994;40:1703-6.
31. Maurer HH. Methods for GC-MS. In: Pfleger K, Maurer HH, Weber A, eds. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. 2nd ed, pt 1. Weinheim: VCH, 1992:3-32.
32. McLafferty FW, Turecek F. Interpretation of mass spectra. 4th ed. Mill Valley: University Science Books, 1993.
33. Ensslin HK, Maurer HH, Gouzoulis E, Hermle L, Kovar K-A. Metabolism of racemic 3,4-methylenedioxyethylamphetamine (MDE) in humans. Drug Metab Dispos (in press).
34. Maurer HH, Moeller MR, Kovar K-A, Kraemer T. On the metabolism and the toxicological analysis of 3,4-methylenedioxymethamphetamine by GC-MS. J Chromatogr [B] (in preparation).
35. Maurer HH, Bock K, Kraemer T. Designer drugs BDB and MBDB - human metabolism and toxicological detection by GC-MS. Abstract Book of 33rd International Congress on Forensic (TIAFT) and 1st on Environmental Toxicology, Thessaloniki, 1995:101.
36. Liebich HM, Foerst C. Basic profiles of organic acids in urine. J Chromatogr 1990;525:1-14.
37. Caldwell J. The metabolism of amphetamines in mammals. Drug Metab Rev 1976;5:219-80.
38. Kraemer T, Kovar K-A, Maurer HH. On the phase II metabolism of the methylenedioxyphenylalkylamine designer drugs MDA, MDMA, MDE, BDB and MBDM in humans. J Chromatogr [B] (in preparation).
39. Maurer HH. Systematic toxicological analysis of drugs and their metabolites by gas chromatography-mass spectrometry. J Chromatogr 1992;580:3-41.
40. Maurer HH. Toxicological analysis of drugs and poisons by GC-MS. Spectrosc Eur 1994;6:21-3.
41. Ensslin HK, Kovar K-A, Maurer HH. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS). J Chromatogr [B] (in press).
42. Pfleger K, Maurer HH, Weber A. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. 3rd ed. Weinheim: VCH (in preparation).
43. Pfleger K, Maurer HH, Weber A. Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites. Palo Alto: Hewlett Packard (in preparation).